Buying From Lonza? A Scenario-Based Procurement Checklist After $40K in Mistakes

There's no one-size-fits-all answer for Lonza orders

I've been handling chemical and life science purchase orders for eight years. I've personally made (and documented) 14 significant mistakes, totaling roughly $40,000 in wasted budget. Now I maintain our team's supplier checklist, so the next person doesn't repeat my errors.

When someone asks if Lonza is the right supplier, I don't give a single "yes" or "no." It depends on what you're buying: an API manufacturing project, a cell culture medium like Lonza DMEM formulation, or a facility order of Lonza pool chemicals. Those are not the same procurement problem. If you treat them the same, you'll pay for it.

The one rule that applies across all scenarios: transparency. I've learned to ask "what's NOT included" before "what's the price." The vendor who lists all fees upfront—even if the total looks higher—usually costs less in the end.

Three scenarios, three checklists

Here's how I sort Lonza requests in my head:

• Scenario A: Regulated pharma products or CDMO services, such as an API project or a branded generic like Sildenafil 1 A Pharma®.
• Scenario B: Cell culture media for lab, research, or bioprocess work, including the Lonza DMEM formulation.
• Scenario C: Non-pharma specialty chemicals, including Lonza pool chemicals for water treatment or facility maintenance.

The classification matters more than the brand name. Let me take each one.

Scenario A: Pharma and CDMO buying is about documentation

If you're sourcing a pharma product or outsourcing manufacturing, the price per unit is almost irrelevant compared with the cost of a documentation gap. I learned this in my first year (2017) when I made the classic specification error: I assumed "standard" meant the same thing to every vendor. It didn't. What I called standard acceptance criteria, the vendor read as a helpful starting point. We caught the mismatch only during an audit. That cost us a rework, a delay, and some credibility.

For regulated products, ask for the whole trail: batch records, stability data, certificate of analysis, GMP evidence, and the regulatory support the supplier actually provides. If you're dealing with a product like Sildenafil 1 A Pharma®, for example, "just a quote" is never just a quote. The real cost is in traceability and compliance.

"The supplier that shows you all the extra fees up front is the one I trust. Surprise charges later are a red flag."

I have mixed feelings about rush fees in this world. Part of me thinks they're gouging; another part has seen how much disruption a rushed regulatory package causes. I compromise by asking for standard lead times first, and then comparing the gap to rush charges. If I remember correctly, our last rush request added about 30% to the fee. Knowing that in advance made the decision easier.

Scenario B: Cell culture media is a different kind of precision

Cell culture media is where I made one of my more embarrassing mistakes. I ordered what I thought was the standard Lonza DMEM formulation. The supplier heard "DMEM/F12." We were using the same words but meaning different things by "standard." The order arrived, the glucose and nutrient ratios were wrong for our cells, and 50 liters became a very expensive paperweight.

The Lonza DMEM formulation itself works well when you specify exactly what you need. The lesson: always include the catalog number, glucose concentration, L-glutamine status, sodium pyruvate, phenol red, and lot-specific certificate of analysis. (Should mention: If you need a custom variant, ask about minimum order quantities and lead time before you fall in love with the idea.)

One contrarian piece of advice: for small lab orders, you may not need a full CDMO relationship. If you need 5 liters for an experiment, buy a verified off-the-shelf medium instead of custom manufacturing. But if you're moving to clinical production, then you want the documented, GMP-grade version. Those are two different buying scenarios, even with the same supplier.

The most frustrating part of media procurement is that the same mistake keeps happening unless someone owns the checklist. We now require the exact catalog number on every order. Our error rate is much lower.

Scenario C: Pool chemicals and other non-pharma purchases have hidden logistics

Lonza pool chemicals are in a different category from pharmaceutical ingredients. They aren't there for a clinical application; they're there to keep a pool safe and clean. That doesn't mean you can lower your guard on paperwork.

On a pool chemical order, the mistake wasn't the product. It was the freight. The quote looked reasonable, and then the "actual" hazmat shipping charge appeared. The total jumped by $200 plus a three-day delay. I should have asked about freight classification first.

The same principle applies to chemical questions outside procurement. A colleague once asked me, "Can you remove builder gel with acetone?" The short answer: yes, acetone will soften or remove builder gel, but it's not the safest recommended method for most people. You can damage the surrounding skin or the underlying nail if you don't know what you're doing. That's a chemistry-specific question, not a Lonza pool chemical question, but it's a good reminder—use the right product for the job.

For pool chemicals, ask for the Safety Data Sheet before ordering, not after. Ask what's included in delivery, whether hazmat fees apply, what the minimum shelf life is, and how much buffer you need for the reorder lead time. If the supplier gives you a total-cost breakdown with a line for "not included," that's a good sign.

Why transparency matters in digital marketing in pharma

I've run into the same transparency issue in marketing work. Digital marketing in pharma is not just about a nice landing page. It's about making claims that you can back up, and not hiding risks in small print. Per FTC advertising guidelines (ftc.gov), claims need to be truthful, substantiated, and clear. That isn't a constraint—it's the whole point.

When pricing a marketing campaign, I also check public print costs as a sanity check. According to online printer pricing, as of January 2025, 1,000 flyers (8.5×11, 100lb gloss text, single-sided) run about $80-150 online and $150-300 at local shops. Prices exclude shipping, so the same "what's not included" question applies to marketing collateral too. If you're sending follow-up collateral by mail, it's also worth checking USPS rates: according to usps.com, a First-Class Mail letter is $0.73 and a large envelope is $1.50 as of January 2025.

If you're doing digital marketing in pharma, the question to start with is: What can we prove? The best marketing won't save a claim that falls apart in review.

How to know which scenario you're in

Still not sure? Try these questions:

1. What's the end use? Human pharma or regulated biotech? That's Scenario A. Lab research or bioprocess that isn't regulated? That's Scenario B. Pool/water treatment or general industrial use? That's Scenario C.
2. What documents do you need? GMP batch documentation and regulatory filings point to A. A certificate of analysis and lot traceability point to B. An SDS and shipping compliance point to C.
3. How much flexibility do you have? If your specs are locked, you're in A or B. If you're comparing options based on cost and availability, you may be in C.

When in doubt, ask the "not included" question. If a vendor won't give you a total cost breakdown, you've learned something without spending a dollar. The checklist exists because I learned this the expensive way. It might save you from your own first-year mistake.